- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00560365
Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer
A Randomised Controlled Trial to Assess the Cost-effectiveness of Intensive Versus no Scheduled Follow-up in Patients Who Have Undergone Resection for Colorectal Cancer With Curative Intent. (FACS - Follow-up After Colorectal Surgery)
RATIONALE: Following patients who have undergone surgery for colorectal cancer may help doctors learn more about the disease and plan better follow-up care.
PURPOSE: This randomized clinical trial is following patients who have undergone surgery for stage I, stage II, or stage III colorectal cancer.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
OBJECTIVES:
Primary
- To assess the effect of augmenting symptomatic follow-up in primary care with two intensive methods of follow-up (monitoring tumor marker in primary care and intensive imaging in hospital) on survival of patients with stage I, II, or III colorectal cancer who have undergone curative resection.
Secondary
- Determine the quality of life of these patients.
- Determine the cost of National Health Service (NHS) services utilized.
- Determine the NHS cost per life-year saved.
OUTLINE: This is a multicenter study. Patients are stratified according to certainty of need for imaging follow-up, as determined by the local clinician (uncertain vs certain). Patients are randomized to 1 of 4 follow-up arms.
- Arm I (primary care follow-up): Patients undergo symptomatic follow-up (i.e., are asked to contact their physician if they have symptoms suggestive of disease recurrence). Some patients may also undergo a single CT scan 12-18 months post-randomization.
- Arm II (primary care follow-up): Patients undergo tumor marker measurements (CEA) at baseline, every 3 months for 2 years, and every 6 months for 3 years. Some patients may also undergo a single CT scan 12-18 months post-randomization.
- Arm III (intensive hospital follow-up): Patients undergo CT scan or MRI at baseline, every 6 months for 2 years, and then annually for 3 years.
- Arm IV (primary care and intensive hospital follow-up): Patients undergo primary care and intensive hospital follow-up as in arms II (without the single CT scan) and III.
All patients receive a handbook from their physician detailing possible symptoms suggestive of disease recurrence.
Quality of life is assessed at baseline and then annually for 5 years.
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studieorter
-
-
England
-
Burton-upon-Trent, England, Storbritannien, DE13 0RB
- Rekrytering
- Queen's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1283-566-333
-
Carlisle, England, Storbritannien, CA2 7HY
- Rekrytering
- Cumberland Infirmary
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1228-523-444
-
Chichester, England, Storbritannien, P019 4SE
- Rekrytering
- Saint Richards Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1243-788-122
-
Cosham, England, Storbritannien, PO6 3LY
- Rekrytering
- Queen Alexandra Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-23-9228-6710
-
Cottingham, England, Storbritannien, HU16 5JQ
- Rekrytering
- Castle Hill Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1482-659-331
-
Crewe, England, Storbritannien, CW1 4QJ
- Rekrytering
- Mid Cheshire Hospitals Trust- Leighton Hopsital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1270-255-141
-
Croydon, England, Storbritannien
- Rekrytering
- Mayday University Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8401-3000
-
Dartford Kent, England, Storbritannien, DA2 8DA
- Rekrytering
- Darent Valley Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1322-428-500
-
Derby, England, Storbritannien, DE22 3NE
- Rekrytering
- Royal Derby Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1332-340-131
-
Dudley, England, Storbritannien, DY1 2HQ
- Rekrytering
- Russells Hall Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1384-456-111
-
Grantham, Lincolnshire, England, Storbritannien, NG31 8DG
- Rekrytering
- Grantham and District Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1476-565-232
-
Harrogate, England, Storbritannien, HG2 7SX
- Rekrytering
- Harrogate District Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1423-885-959
-
Harrow, England, Storbritannien, HA1 3UJ
- Rekrytering
- St. Mark's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8235-4000
-
High Wycombe, England, Storbritannien
- Rekrytering
- Wycombe General Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1494-426-234
-
Huntingdon, England, Storbritannien, PE18 6NT
- Rekrytering
- Hinchingbrooke Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1480-416-416
-
Isleworth, England, Storbritannien, TW7 6AF
- Rekrytering
- West Middlesex University Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8560-2121
-
Leeds, England, Storbritannien, LS1 3EX
- Rekrytering
- Leeds General Infirmary
-
Kontakt:
- Contact Person
- Telefonnummer: 44-113-243-2799
-
London, England, Storbritannien, W6 8RF
- Rekrytering
- Charing Cross Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-8846-1234
-
Maidstone, England, Storbritannien, ME16 9QQ
- Rekrytering
- Mid Kent Oncology Centre at Maidstone Hospital
-
Nottingham, England, Storbritannien, NG7 2UH
- Rekrytering
- Queen's Medical Centre
-
Kontakt:
- Contact Person
- Telefonnummer: 44-115-924-9924
-
Plymouth, England, Storbritannien, PL6 8DH
- Rekrytering
- Derriford Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-175-277-7111
-
Scarborough, England, Storbritannien, YO12 6QL
- Rekrytering
- Scarborough General Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1723-342-175
-
Shrewsbury, England, Storbritannien, SY3 8XQ
- Rekrytering
- Royal Shrewsbury Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1743-261-000
-
Slough, Berkshire, England, Storbritannien, SL2 4HL
- Rekrytering
- Wexham Park Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1753-634-191
-
Solihull, England, Storbritannien, B91 2JL
- Rekrytering
- Solihull Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-121-424-2000
-
Southampton, England, Storbritannien, SO16 6YD
- Rekrytering
- Southampton General Hospital
-
Surrey, England, Storbritannien, KT 16 OPZ
- Rekrytering
- St. Peter's Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1932-722-233
-
Truro, Cornwall, England, Storbritannien, TR1 3LJ
- Rekrytering
- Royal Cornwall Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1872-250-000
-
Uxbridge, England, Storbritannien, UB8 3NN
- Rekrytering
- Hillingdon Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1895-238-282
-
Warrington, England, Storbritannien, WA5 1QG
- Rekrytering
- Warrington Hospital NHS Trust
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1925-635-911
-
Worcester, England, Storbritannien, WR5 1DD
- Rekrytering
- Worcester Royal Hospital
-
Kontakt:
- Contact Person
- Telefonnummer: 44-1905-760-719
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
DISEASE CHARACTERISTICS:
Diagnosis of primary colorectal cancer
- Stage I-III disease
Have undergone curative resection (i.e., no residual disease [R0])
- Microscopically clear margins
- Complete normal colonic imaging pre-operatively (or post-operatively if unable to view complete colon pre-operatively) by colonoscopy, barium enema, CT pneumocolon, or virtual colonoscopy
Post-operative blood CEA ≤ 10 ng/mL (if the normal range is ≤ 5 ng/mL) OR < 2 times upper limit of normal (if normal range is > 5 ng/mL)
- For patients undergoing adjuvant therapy, CEA should be measured after completion of chemotherapy
Has completed primary curative treatment, as deemed by hospital clinician
- Patients awaiting stoma closure allowed
- No evidence of metastatic disease on pre- or post-operative liver CT scan (or ultrasound) and chest CT scan (or chest x-ray)
- No diagnosis of familial adenomatous polyposis (FAP) or dominantly inherited colon cancer
PATIENT CHARACTERISTICS:
- No concurrent serious illness
- History of other carcinoma allowed provided primary treatment has been completed, there is no evidence of recurrent disease, and there is no follow-up that conflicts with study follow-up
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- Pre-operative radiotherapy or chemoradiotherapy for rectal cancer allowed provided curative resection has been achieved
- No concurrent participation in a primary treatment clinical trial with conflicting follow-up requirements
Studieplan
Hur är studien utformad?
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
Overall survival by intention-to-treat analysis
|
Sekundära resultatmått
Resultatmått |
---|
Livskvalité
|
Cost of National Health Service (NHS) services utilized
|
NHS cost per life-year saved
|
Samarbetspartners och utredare
Utredare
- Studiestol: John N. Primrose, MD, University Hospital Southampton NHS Foundation Trust
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CDR0000576476
- USCTU-FACS
- ISRCTN41458548
- EU-20788
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Kolorektal cancer
-
Incyte CorporationMerck Sharp & Dohme LLCAvslutadMelanom | Lymfom | Huvud- och halscancer | Magcancer | Äggstockscancer | Hepatocellulärt karcinom (HCC) | Lungcancer | Blåscancer | Endometriecancer | Fasta tumörer | Njurcellscancer (RCC) | Trippel negativ bröstcancer (TNBC) | UC (Urotelial cancer) | Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Förenta staterna
Kliniska prövningar på datortomografi
-
Central Hospital, Nancy, FranceAvslutad
-
Peking Union Medical College HospitalRekrytering
-
Universitätsklinikum Hamburg-EppendorfSiemens Healthcare Diagnostics IncHar inte rekryterat ännuKranskärlssjukdom | Akut ischemisk stroke
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AvslutadMalign neoplasm | Metastatisk malign neoplasm i hjärnanFörenta staterna
-
M.D. Anderson Cancer CenterRekryteringKarcinoid tumör | Carcinoid syndrom | Metastaserande karcinoidtumör | Matsmältningssystemet Neuroendokrina tumörer G1Förenta staterna
-
Istituto Ortopedico RizzoliAvslutadPatello femoralt syndromItalien
-
AZ Sint-Jan AVAktiv, inte rekryterandeSvårt atrofisk käkeBelgien
-
Paragon 28Focus Medical Design and DevelopmentAvslutad
-
FLUIDDA nvAvslutad
-
University Hospital, Strasbourg, FranceAvslutad